International Journal of Infection

Published by: Neoscriber Demo Publisher
Crossmark

Frequency of Viral Transfusion-Transmitted Infections (TTIs) Among Resident and Pilgrim Blood Donors in Mashhad, 2011

Mohammad Reza Hedayati-Moghaddam ORCID 1 , * , Farzad Mollahosseini Foomani 2 , 3 and Arezoo Gowhari Shabgah 1
Authors Information
1 Blood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan Branch, Mashhad, Iran
2 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
3 Razavi Khorasan Regional Blood Transfusion Center, Mashhad, Iran
Article information
  • International Journal of Infection: April 30, 2019, 6 (2); e87350
  • Published Online: April 20, 2019
  • Article Type: Research Article
  • Received: December 11, 2018
  • Revised: March 30, 2019
  • Accepted: April 7, 2019
  • DOI: 10.5812/iji.87350

To Cite: Hedayati-Moghaddam M R , Mollahosseini Foomani F , Gowhari Shabgah A. Frequency of Viral Transfusion-Transmitted Infections (TTIs) Among Resident and Pilgrim Blood Donors in Mashhad, 2011, Int J Infect. 2019 ; 6(2):e87350. doi: 10.5812/iji.87350.

Abstract
Copyright © 2019, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Deressa T, Birhan W, Enawgaw B, Abebe M, Baynes HW, Desta M, et al. Proportion and predictors of transfusion-transmissible infections among blood donors in North Shewa Zone, Central North Ethiopia. PLoS One. 2018;13(3). e0194083. doi: 10.1371/journal.pone.0194083. [PubMed: 29579055]. [PubMed Central: PMC5868787].
  • 2. Mohammadali F, Pourfathollah AA. Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011. Arch Iran Med. 2014;17(9):613-20. [PubMed: 25204477].
  • 3. Mohsenizadeh M, Mollaei HR, Ghaziizadeh M. Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman. Asian Pac J Cancer Prev. 2017;18(12):3267-72. doi: 10.22034/APJCP.2017.18.12.3267. [PubMed: 29286218]. [PubMed Central: PMC5980882].
  • 4. Murphy EL. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety. Transfus Clin Biol. 2016;23(1):13-9. doi: 10.1016/j.tracli.2015.12.001. [PubMed: 26778839]. [PubMed Central: PMC5042452].
  • 5. Rawat A, Diwaker P, Gogoi P, Singh B. Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India. Indian J Med Res. 2017;146(5):642-5. doi: 10.4103/ijmr.IJMR_468_15. [PubMed: 29512607]. [PubMed Central: PMC5861476].
  • 6. Flichman DM, Blejer JL, Livellara BI, Re VE, Bartoli S, Bustos JA, et al. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors. BMC Infect Dis. 2014;14:218. doi: 10.1186/1471-2334-14-218. [PubMed: 24755089]. [PubMed Central: PMC4018657].
  • 7. World Health Organization. Blood safety and availability. 2015. Available from: http://www.who.int/mediacentre/factsheets/fs279/en/.
  • 8. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009;49(10):2214-20. doi: 10.1111/j.1537-2995.2009.02245.x. [PubMed: 19527477].
  • 9. Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg prevalence among blood donors from eastern Mediterranean and Middle Eastern Countries: A systematic review and meta-analysis. Hepat Mon. 2016;16(3). e35664. doi: 10.5812/hepatmon.35664. [PubMed: 27226804]. [PubMed Central: PMC4875562].
  • 10. Khodabandehloo M, Roshani D, Sayehmiri K. Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis. J Res Med Sci. 2013;18(8):674-82. [PubMed: 24379843]. [PubMed Central: PMC3872606].
  • 11. Song Y, Bian Y, Petzold M, Ung CO. Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010. PLoS One. 2014;9(4). e94528. doi: 10.1371/journal.pone.0094528. [PubMed: 24714490]. [PubMed Central: PMC3979838].
  • 12. Abolghasemi H, Maghsudlu M, Kafi-Abad SA, Cheraghali A. Introduction to Iranian blood transfusion organization and blood safety in Iran. Iran J Public Health. 2009;38(1):82-7.
  • 13. Keshvari M, Sharafi H, Alavian SM, Mehrabadi H, Zolfaghari S. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013. Transfus Apher Sci. 2015;53(1):38-47. doi: 10.1016/j.transci.2015.03.003. [PubMed: 25892591].
  • 14. Ahmadi Ghezeldasht S, Miri R, Hedayatimoghadam M, Shamsian A, Bidkhori H, Fathimoghadam F, et al. Population movement and virus spreading: HEV spreading in a pilgrimage city, Mashhad in Northeast Iran; an example. Hepat Mon. 2013;13(8). e10255. doi: 10.5812/hepatmon.10255. [PubMed: 24171006]. [PubMed Central: PMC3810681].
  • 15. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011;52(3):172-6. doi: 10.1016/j.jcv.2011.07.004. [PubMed: 21840754].
  • 16. Hedayati-Moghaddam MR. A systematic review for estimation of HTLV-I Infection in the blood donors of Iran. Iran J Basic Med Sci. 2013;16(3):196-201. [PubMed: 24470861]. [PubMed Central: PMC3881243].
  • 17. Karimi G, Zadsar M, Pourfathollah AA. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran. Virol J. 2017;14(1):14. doi: 10.1186/s12985-017-0693-9. [PubMed: 28137274]. [PubMed Central: PMC5282699].
  • 18. Safabakhsh H, Jalalian M, Karimi G. Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad. Glob J Health Sci. 2014;6(5):99-104. doi: 10.5539/gjhs.v6n5p99. [PubMed: 25168999]. [PubMed Central: PMC4825399].
  • 19. Farshadpour F, Taherkhani R, Tajbakhsh S, Gholizadeh Tangestani M, Hajiani G, Sharifi N, et al. Prevalence and trends of transfusion-transmissible viral infections among blood donors in South of Iran: An eleven-year retrospective study. PLoS One. 2016;11(6). e0157615. doi: 10.1371/journal.pone.0157615. [PubMed: 27309959]. [PubMed Central: PMC4911153].
  • 20. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011;11(5):346-50. [PubMed: 22087159]. [PubMed Central: PMC3212777].
  • 21. Ahmadi Ghezeldasht S, Hedayati-Moghaddam MR, Shamsian K, Fathimoghadam F, Bidkhori HR, Rezaee SA. Prevalence of hepatitis C virus infection in general population of Mashhad, Northeastern Iran. Iran J Public Health. 2017;46(3):408-13. [PubMed: 28435827]. [PubMed Central: PMC5395537].
  • 22. Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B virus infection in the general population of Iran: An updated systematic review and meta-analysis. Hepat Mon. 2016;16(4). 35577. doi: 10.5812/hepatmon.35577. [PubMed: 27257428]. [PubMed Central: PMC4888501].
  • 23. Musavi H, Rahimi H, Kooti W, Dorostkar R, Azami M, Sharghi M, et al. Prevalence of human immunodeficiency virus in Iranian blood donors: A systematic review and meta-analysis. Arch Iran Med. 2018;21(6):260-7. [PubMed: 29940745].
  • 24. Miri R, Ahmadi Ghezeldasht S, Mosavat A, Hedayati-Moghaddam MR. No evidence of HIV infection among the general population of Mashhad, Northeast of Iran. Jundishapur J Microbiol. 2017;10(3). doi: 10.5812/jjm.43655.
  • 25. Salawu L, Bolarinwa RA, Adegunloye AB, Muraina HA. HBsAg, anti-HCV, anti-HIV and VDRL in blood donors: Prevalence and trends in the last three and a half years in a tertiary health care facility in Ile-Ife, Nigeria. Int J Med Med Sci. 2010;2(11):335-41.
  • 26. Arshad A, Borhany M, Anwar N, Naseer I, Ansari R, Boota S, et al. Prevalence of transfusion transmissible infections in blood donors of Pakistan. BMC Hematol. 2016;16:27. doi: 10.1186/s12878-016-0068-2. [PubMed: 27891232]. [PubMed Central: PMC5116208].
  • 27. Teklemariam Z, Mitiku H, Weldegebreal F. Seroprevalence and trends of transfusion transmitted infections at Harar blood bank in Harari regional state, Eastern Ethiopia: Eight years retrospective study. BMC Hematol. 2018;18:24. doi: 10.1186/s12878-018-0115-2. [PubMed: 30237893]. [PubMed Central: PMC6139147].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments